
Humana (HUM) Stock Forecast & Price Target
Humana (HUM) Analyst Ratings
Bulls say
Humana is well-positioned in the healthcare industry due to its strong focus on government-sponsored programs, which make up a majority of its membership. With the expected 25% y/y growth in Individual MA membership and recontracting in the Group MA sector, Humana is poised for continual growth. The company has also been actively managing its medical and Rx trends, leading to better financial performance, and we expect this trend to continue in the foreseeable future.
Bears say
Humana is a healthcare company that specializes in government-sponsored programs such as Medicare, Medicaid, and Tricare. However, with a recent downturn in the Medicare Advantage program and uncertainty surrounding future margins, we believe Humana may struggle to maintain its current level of profitability. Additionally, the company's reliance on government programs exposes it to potential changes in regulations and reimbursements.
This aggregate rating is based on analysts' research of Humana and is not a guaranteed prediction by Public.com or investment advice.
Humana (HUM) Analyst Forecast & Price Prediction
Start investing in Humana (HUM)
Order type
Buy in
Order amount
Est. shares
0 shares